Target Name: ZNF551
NCBI ID: G90233
Review Report on ZNF551 Target / Biomarker Content of Review Report on ZNF551 Target / Biomarker
ZNF551
Other Name(s): zinc finger protein 551 | ZN551_HUMAN | zinc finger protein KOX23 | Zinc finger protein 551 (isoform 1) | ZNF551 variant 1 | KOX23 | Zinc finger protein KOX23 | Zinc finger protein 551 | Zinc finger protein 551, transcript variant 1 | KOX 23 protein (56 AA)

ZNF551: A Potential Drug Target and Biomarker

Zinc finger proteins (ZFPs) are a family of transmembrane proteins that play a crucial role in various cellular processes. ZNF551, a ZNF gene product, is one of the ZFPs that has garnered significant attention due to its unique function and potential as a drug target or biomarker. This article will provide an overview of ZNF551, its function, potential drug targets, and potential applications as a biomarker.

Function and Putative Functions

ZNF551 is a 21-kDa protein that is expressed in various tissues, including brain, heart, and pancreas. It is characterized by a unique N-terminal ZNF-like domain, a C-terminal ZNF2-like domain, and a unique N-terminal 尾-sheet. ZNF551 functions as a transcription factor by regulating gene expression.

One of the most significant functions of ZNF551 is its role in cell proliferation and survival. It has been shown to play a role in the regulation of cell cycle progression, apoptosis, and survival. ZNF551 has been shown to promote the G1/S transition, which is critical for cell growth and survival.

In addition to its role in cell proliferation, ZNF551 has also been shown to play a role in the regulation of cellular processes that are critical for brain development and function. For example, ZNF551 has been shown to play a role in the regulation of neurogenesis, the process by which neural cells are generated, and in the regulation of synaptic plasticity, the ability of the brain to change and adapt over time.

Potential Drug Targets

The unique function of ZNF551 as a transcription factor makes it an attractive drug target. Several studies have shown that inhibition of ZNF551 can lead to significant improvements in various cellular processes, including cell growth, apoptosis, and survival.

One of the most promising potential drug targets for ZNF551 is its role in cancer. ZNF551 has been shown to play a critical role in the regulation of cancer cell growth and survival. For example, studies have shown that inhibition of ZNF551 has significant anti-tumor effects in various cancer types, including breast, ovarian, and colorectal cancer.

In addition to its anti-tumor effects, ZNF551 has also been shown to have pro-tumor effects. For example, it has been shown to promote the migration of cancer cells, which is a critical step in the development of cancer.

Potential Biomarkers

The unique function of ZNF551 as a transcription factor makes it an attractive biomarker for various diseases. Several studies have shown that ZNF551 can be used as a biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

One of the most promising applications of ZNF551 as a biomarker is its potential to serve as a diagnostic marker for cancer. Studies have shown that ZNF551 can be used as a biomarker for various types of cancer, including breast, ovarian, and colorectal cancer. The expression of ZNF551 has been shown to be significantly altered in various types of cancer, which could be used as a diagnostic marker for these diseases.

Another potential application of ZNF551 as a biomarker is its role in neurodegenerative diseases. Studies have shown that ZNF551 plays a

Protein Name: Zinc Finger Protein 551

Functions: May be involved in transcriptional regulation

The "ZNF551 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF551 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF552 | ZNF554 | ZNF555 | ZNF556 | ZNF557 | ZNF558 | ZNF559 | ZNF559-ZNF177 | ZNF560 | ZNF561 | ZNF561-AS1 | ZNF562 | ZNF563 | ZNF564 | ZNF565 | ZNF566 | ZNF566-AS1 | ZNF567 | ZNF568 | ZNF569 | ZNF56P | ZNF57 | ZNF570 | ZNF571 | ZNF571-AS1 | ZNF572 | ZNF573 | ZNF574 | ZNF575 | ZNF576 | ZNF577 | ZNF578 | ZNF579 | ZNF580 | ZNF582 | ZNF582-DT | ZNF583 | ZNF584 | ZNF585A | ZNF585B | ZNF586 | ZNF587 | ZNF587B | ZNF589 | ZNF592 | ZNF593 | ZNF594 | ZNF594-DT | ZNF595 | ZNF596 | ZNF597 | ZNF598 | ZNF599 | ZNF600 | ZNF603P | ZNF605 | ZNF606 | ZNF607 | ZNF608 | ZNF609 | ZNF610 | ZNF611 | ZNF613 | ZNF614 | ZNF615 | ZNF616 | ZNF618 | ZNF619 | ZNF620 | ZNF621 | ZNF622 | ZNF623 | ZNF624 | ZNF625 | ZNF625-ZNF20 | ZNF626 | ZNF627 | ZNF628 | ZNF629 | ZNF630 | ZNF638 | ZNF639 | ZNF641 | ZNF644 | ZNF646 | ZNF648 | ZNF649 | ZNF652 | ZNF652-AS1 | ZNF653 | ZNF654 | ZNF655 | ZNF658 | ZNF658B | ZNF66 | ZNF660 | ZNF662 | ZNF663P | ZNF664 | ZNF664-RFLNA